Renee Berry Peter Hollingsworth Michaela Lucas
10.1002/cti2.1075
Clin Transl Immunology
2019 Sep 30;8(10):e01075.
bee venom immunotherapy idiopathic non‐clonal mast cell disorder mast cell activation syndrome omalizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/31576204/
Case Reports
PMC6768441
31576204
Successful treatment of idiopathic mast cell activation syndrome with low-dose Omalizumab
2019